Indivior receives settlement approval for antitrust litigation

(Sharecast News) - Pharmaceuticals business Indivior has received final court approval for a landmark settlement in an antitrust multi-district litigation with the direct purchaser class. Indivior said on Thursday that on 27 February, the United States District Court for the Eastern District of Pennsylvania entered an order granting final judgement and order of dismissal approving its direct purchaser class settlement and dismissing direct purchaser class claims.

The FTSE 250-listed group noted that the ruling, which follows a $385.0m settlement agreement in October 2023, now concludes the antitrust multi-district litigation .

As of 0945 GMT, Indivior shares were up 0.99% at 1,736.0p.



Reporting by Iain Gilbert at Sharecast.com